creatine kinase MM in blood; GSP Neonatal Creatine Kinase-MM kit
Jump to navigation
Jump to search
Indications
Clinical significance
- elevated levels may be asssociated with Duchenne muscular dystrophy
Methods
- electrophoresis (presumptive)
Specimen
- heel stick collected 24 to 48 hours after birth.
More general terms
Additional terms
References
- ↑ FDA News Release. December 12, 2019 FDA authorizes first test to aid in newborn screening for Duchenne Muscular Dystrophy. https://www.fda.gov/news-events/press-announcements/fda-authorizes-first-test-aid-newborn-screening-duchenne-muscular-dystrophy